Thomayer University Hospital
Prague, 140 59, Czechia
Location status: Recruiting
NCT Number: NCT05323916
In this study, the investigators aim to assess the effectiveness of the Comprehensive Intensive Rehabilitation Program After Stroke implementing the International Classification of Functioning, Disability and Health model, and to compare it with two cohorts receiving Comprehensive Intensive Rehabilitation Program After Stroke of the same length but different in physical therapy content (program implementing modern technological approach and neuroproprioceptive "facilitation and inhibition"). Moreover, control group will undergo standard care.
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Not applicable
Prague, 140 59, Czechia
Location status: Recruiting
Aim of this study is to define the predictors of effective rehabilitation after stroke. In order to compare the improvement from many different aspects, a wide range of patient characteristic, self-report measures and clinical assessments according to framework of the International Classification of Functioning, Disability and Health (ICF) model, and other data will be collected. The investigators consider, as the most important aspect, the subjective feelings of the participants about how they improved. Therefore, the Goal Attainment scale together with the Patient-reported Outcomes Measurement Information Global Health, and the World Health Organization Disability Assessment Schedule were chosen as primary outcomes. As secondary outcomes, will be measured the motor, cognitive, psychological, speech and swallowing functions and the functional independence. Moreover, focus will be placed on the identification of novel biological molecules reflective of effective rehabilitation.
This clinical trial will test the following scientific hypotheses:
I. COMIRESTROKE under all three settings has a positive influence on all outcomes and higher effect than control group. .
II. COMIRESTROKE - ICF will have the highest impact on primary outcomes (GAS, PROMIS, WHODAS 2.0) and on such secondary outcomes that were identified as treatment goals. Furthermore, it is expected that the highest impact will be on the primary outcomes in the follow-up (three and twelve months after finishing the rehabilitation).
III. COMIRESTROKE - NEFI will have the highest effect on the secondary outcomes, mainly on motor functions. Moreover, it will most significantly lead to the initiation of plastic and adaptive processes, assessed by the level of lncRNAs in the peripheral blood.
IV. The most important predictor of effective rehabilitation will be the level of disability at admission time; however, the content of the rehabilitation will have an impact on perceived, clinical, and physiological changes of the rehabilitant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo a standard comprehensive intensive rehabilitation program three hours a day for three weeks and moreover one hour a day of neuroproprioceptive "facilitation, inhibition" physical therapy.
Participants will undergo a standard comprehensive intensive rehabilitation program three hours a day for three weeks and moreover one hour a day of technology based physical therapy.
Participants will undergo a four hour a day for three weeks of effectively managed comprehensive intensive rehabilitation implementing the recommendations of the World Health Organization.
Participants will undergo standardly provided care including face to face physiotherapy (bed mobility, transfers, gait, therapeutic exercises, positioning, education).
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks), Follow up assessments (3 and 12 months after the admission respectively)
a 10 item scale that assesses an individual's physical, mental, and social health where a standardized score with a mean of 50 and a standard deviation of 10, so a person with a T-score of 40 is one SD below the mean.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks). Follow up assessments (3 and 12 months after the admission respectively).
the 36-item questionnaire, higher score means higher disability
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks). Follow up assessments (3 and 12 months after the admission respectively).
Each goal is rated on 5-point scale (-2 much less than expected, 0 achieved the expected level, 2 much more than expected). Higher score means a better outcome.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
isometric grip force and strength. The higher value, the better function (higher strength)
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
The spectral characteristic of postural tremor measured by the 3-axis accelerometer and 3-axis gyroscope chip (Motion Tracking sensor MPU-6050) - a power of the signal in band from f1 to f2 - lower value, lower tremor.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
The spectral characteristic of postural tremor measured by the 3-axis accelerometer and 3-axis gyroscope chip (Motion Tracking sensor MPU-6050) - a frequency for which the smoothed power spectral density is maximal - lower value, lower tremor.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A client takes the pegs from a container, one by one, and places them into the holes on the board, as quickly as possible. Shorter times reflect better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A 19 item observational measure to assess upper extremity performance (coordination, dexterity and functioning). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
Measure real-world upper extremity function. The MAL adopts a 6-point ordinal scale (0 - 5). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
The subject stands up from a chair, walks 3m, turns back, and sits down again as quickly and safely as possible while being timed. Higher times reflect worse mobility.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A 14-task scale that requires subjects to maintain their balance in positions and tasks of increasing difficulty (0 - 56). Higher score means better balance.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A performance measure used to assess walking speed in meters per second over 10 meters. Shorter times reflect better mobility.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A long walking capacity test recording the maximal distance a subject walks at the fastest speed possible in 6 minutes. The more distance covered, the better the walking performance is.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
An 18-item measurement tool that explores an individual's physical, psychological and social function. Higher score is better (higher independence).
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
It assesses the severity of aspiration risk (0 - 20). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
The overall Index of Dysarthria (ID) is a sum of 45 items with the maximum score of 90 (the best function). This examination will be recorded and analysed by the beta version of the freely available Dysarthria Analyzer (Czech Technical University in Prague, available at http://dysan.cz/)
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
A brief, repeatable screening measure for individuals with severely impaired communication/language skills. The sum of subtests 1-3 and 8-9 scores forms the MAST-E (range 0-50), while the subtests 4-7 form the MAST-R (range 0-50), and the sum of all subtests forms the MAST-T (range 0-100). Higher score, better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
a test of confrontational naming of nouns and verbs. Words are selected based on success, frequency of occurrence, age of adoption, length, and visual complexity. The maximum sum is 60 points (30 verbs and 30 nouns), the results can be assessed qualitatively according to the type of unexplained words (0 - 60). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
the original Czech and innovative test of how to easily (therefore in the name Light) and quickly examine the state of memory (therefore Amnesia Assessment) within two to three minutes (therefore Brief). The sum, called ALBA score, is derived from correctly recalled words of the sentence and correctly recalled gestures together (W2 + G2: 0-12). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
an original Czech and short test, the purpose of which is to quickly check simultaneously written speech, long-term semantic and short-term visual memory. The title describes the main content of testing and the abbreviation POBAV (Naming Pictures and Their Equipment) was created from the key letters. The task of the examinee is to write the names of 20 pictures in one word and at the same time remember them. Participant is then asked to rewrite the names of the pictures he remembers (0 - 20). Higher score means better function.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
a self-report of health-related quality of life in domain concerning depression, The T-score rescales the raw sum score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. Therefore, a person with a T-score of 40 is one SD below the mean, while a person who has T-score of 60 is one standard deviation better (healthier) than the general population.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks)
an assesment for detecting cognitive impairment ranged between 0 and 30 points. The more the better.
Time frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three weeks), Follow up at 3 and 12 months.
LncRNAs are defined as RNA transcripts >200 nucleotides with limited coding potential, but multiple function of binding different DNA, mRNAs and proteins, and they can be expressed under different conditions. As an improvement will be interpreted a significant mean fold change in gene expression (≥ 2.0, p value ≤ 0.05) between two groups following endogenous gene standardisation and normalization through control adjustment to a value of 1.0.
Contact information is provided by the study sponsor or research team.
Charles University, Czech Republic
Other
Motor Recovery Following the Comprehensive Intensive Rehabilitation Program After Stroke Implementing the International Classification of Functioning, Disability and Health Model: A Randomized Controlled Trial Protocol
Acronym: COMIRESTROKE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07525713
Attention, Brain Diseases
Tainan, Taiwan
View Trial DetailsNCT07034521
Brain Diseases, Cardiovascular Diseases
Taipei, Taiwan
View Trial DetailsNCT07139379
Brain Diseases, Cardiovascular Diseases
Tainan, Taiwan
View Trial DetailsNCT05591040
Brain Diseases, Cardiovascular Diseases
Venice-Lido, Italy
View Trial Details